Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Jul 5, 2023
Walvax publishes safety and non-inferior immunogenicity results of its MPV ACYW135 compared with Menactra® in Human Vaccines & Immunotherapeutics
Learn More
Sep 27, 2023
Walvax Participated in the 24th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) in Cape Town, South Africa
Learn More
Sep 18, 2024
Walvax Biotechnology Achieves ESG Rating Upgrade to BBB from MSCI
Learn More